PATENT CLAIM ANALYSIS

Application Number: 15901401
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2018-07
Patent Classification: ["552", "514000"]

Abstract:
Pentacyclic triterpene compounds are provided herein. Also provided are pharmaceutical formulations containing a therapeutically effective amount of one or more of the compounds, or pharmaceutically acceptable salts or prodrugs thereof, in combination with one or more pharmaceutically acceptable excipients. The pharmaceutical formulations can be administered to a pre-obese, obese, or morbidly obese patient to induce weight loss, reduce body fat, reduce food intake, improve glucose homeostasis, prevent obesity, or a combination thereof. The compounds can also be co-administered with leptin or a leptin analog.

Claim (Index 34):
The pharmaceutical formulation of  claim 32 , which is administered in an effective amount to decrease body mass or body fat by at least 15%.

Metadata:
- Claim Count in Document: 2.0
- Percentile: 88.0
- Lexical Diversity: 1.73214
- Patent Class: 552.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14431412', '15644247', '15771077', '15359061', '14509680']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7003163786249474
- 35 USC 102 Novelty (BERT): 0.6824482937788731
- Combined Prediction Score: 0.69852957014034
- Mean Citation Score: 430.5189
- Max Citation Score: 643.8458
- Similarity Product: 464.28900868871216

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test